DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 7.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 60.9. According to RSI analysis, drreddy is technically strong. 9.0 DRREDDY RSI Chart
MACD (?) MACD: 151.0 and Signal Line: 145.0. According to MACD analysis, drreddy is technically strong. 8.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a strong uptrend. Major support levels are 4356.792, 4135.662, 3431.229. 10.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is in a strong uptrend. Major support levels are 4396.343, 4173.995, 3573.518. 10.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.648. 5.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 4397.7628 and 4286.3. Resistance level is 4758.6. 6.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 127 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 38.5 which means DRREDDY is in a trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
August 13, 2020
Open Price 4550.15
High Price 4590.45
Low Price 4491.75
Close Price 4502.25
Absolute Change -15.9
Percentage Change -0.352%
Weekly Change -1.76%
Monthly Change 8.43%
Yearly Change 79%
52-week high 4758.6
52-week low 2351.2
Corporate Actions
ExDate Purpose
July 13, 2020 AGM/DIV-RS 25 PER SH
July 15, 2019 AGM/DIV-RS 20 PER SH
July 16, 2018 AGM/DIV-RS 20 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.483
Confidence in Beta1.75%
Market Capital Rs. 76708.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 13 August 2020: Deliverable Quantity:2.06e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 13 August 2020: Daily Volatility:0.3917 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 13 August 2020: PCR_OI:0.612 PCR:0.4 NA DRREDDY PCR Chart
Option Pain (?) 13 August 2020: Max Pain:4500.0 NA DRREDDY Option Pain Chart
Premium (?) 13 August 2020 Premium: 21.8 Futures OI:3184000.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 13 August 2020: Price:4502.25 Put with maximum OI:4000.0 Call with maximum OI:4700.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
August 27, 2020 4524.05 3184000.0 4575.0 4575.0 4502.25
September 24, 2020 4535.5 43250.0 68.0 68.0 4502.25
October 29, 2020 4550.35 2500.0 3.0 3.0 4502.25


June 18, 2020 Book Closure Dr. Reddy's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 15-Jul-2020 to 17-Jul-2020 for the purpose of Dividend.
May 15, 2019 News Clarification DRREDDY: The Exchange had sought clarification from the Company with respect to news item captioned- titled "Pharma stocks bleed as US states file lawsuit against generic drug firms". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company was aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is attached.
See all Announcements

Board Meetings

Date Meeting Date Purpose
June 29, 2020 July 29, 2020 Financial Results To consider and approve the financial results for the period ended Jun 30, 2020
March 30, 2020 May 13, 2020 Financial Results/Dividend To consider and approve the financial results for the period ended March 31, 2020 and dividend
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play